TreeWAS – Variant ID: rs2954021

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E78.0 Pure hypercholesterolaemia	0.000	0.000	1.000
I25.1 Atherosclerotic heart disease	0.000	0.000	1.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.000	0.001	0.999
E78.5 Hyperlipidaemia, unspecified	0.000	0.002	0.998
I25 Chronic ischaemic heart disease	0.000	0.009	0.991
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.051	0.949
E78.2 Mixed hyperlipidaemia	0.000	0.078	0.922
I25.3 Aneurysm of heart	0.000	0.112	0.888
E78.1 Pure hyperglyceridaemia	0.000	0.117	0.883
I25.2 Old myocardial infarction	0.000	0.125	0.875
I25.4 Coronary artery aneurysm	0.000	0.137	0.863
E78.4 Other hyperlipidaemia	0.000	0.165	0.835
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.208	0.792
E78.8 Other disorders of lipoprotein metabolism	0.000	0.234	0.766
E78.6 Lipoprotein deficiency	0.000	0.276	0.723
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.294	0.706
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.326	0.674
I25.6 Silent myocardial ischaemia	0.000	0.357	0.643
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.393	0.607
E78.3 Hyperchylomicronaemia	0.000	0.413	0.587
I25.5 Ischaemic cardiomyopathy	0.000	0.421	0.579
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.450	0.550
I20-I25 Ischaemic heart diseases	0.000	0.461	0.539
I21 Acute myocardial infarction	0.000	0.461	0.539
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.516	0.484
I21.4 Acute subendocardial myocardial infarction	0.000	0.605	0.395
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.614	0.386
I23 Certain current complications following acute myocardial infarction	0.000	0.688	0.312
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.730	0.270
K76 Other diseases of liver	0.000	0.758	0.242
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.776	0.224
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.776	0.224
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.776	0.224
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.776	0.224
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.776	0.224
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.776	0.224
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.776	0.224
K76.6 Portal hypertension	0.000	0.780	0.220
I21.3 Acute transmural myocardial infarction of unspecified site	0.001	0.780	0.219
I21.9 Acute myocardial infarction, unspecified	0.000	0.786	0.214
I20 Angina pectoris	0.000	0.804	0.196
I22 Subsequent myocardial infarction	0.000	0.809	0.191
K76.7 Hepatorenal syndrome	0.000	0.812	0.188
K76.5 Hepatic veno-occlusive disease	0.000	0.827	0.173
K76.4 Peliosis hepatis	0.000	0.827	0.173
K76.3 Infarction of liver	0.000	0.827	0.173
K76.2 Central haemorrhagic necrosis of liver	0.000	0.827	0.173
K76.9 Liver disease, unspecified	0.000	0.839	0.161
K76.1 Chronic passive congestion of liver	0.000	0.845	0.155
I20.8 Other forms of angina pectoris	0.000	0.850	0.150
I23.8 Other current complications following acute myocardial infarction	0.001	0.851	0.149
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.862	0.138
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.871	0.129
Z95.1 Presence of aortocoronary bypass graft	0.000	0.874	0.126
I20.9 Angina pectoris, unspecified	0.000	0.880	0.120
I20.0 Unstable angina	0.000	0.905	0.095
I24 Other acute ischaemic heart diseases	0.000	0.912	0.088
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.913	0.087
I20.1 Angina pectoris with documented spasm	0.000	0.922	0.077
I22.8 Subsequent myocardial infarction of other sites	0.000	0.924	0.076
I24.1 Dressler's syndrome	0.000	0.944	0.056
I50.1 Left ventricular failure	0.000	0.949	0.051
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.952	0.048
K76.8 Other specified diseases of liver	0.000	0.963	0.037
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.969	0.031
I78.1 Naevus, nonneoplastic	0.000	0.973	0.027
I78 Diseases of capillaries	0.000	0.979	0.021
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.979	0.021
I50 Heart failure	0.000	0.980	0.020
I24.8 Other forms of acute ischaemic heart disease	0.000	0.980	0.020
I50.0 Congestive heart failure	0.000	0.982	0.018
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.018	0.982	0.000
I78.9 Disease of capillaries, unspecified	0.000	0.984	0.016
E10.3 With ophthalmic complications	0.016	0.984	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.015	0.985	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.014	0.986	0.000
B34.9 Viral infection, unspecified	0.000	0.986	0.014
T39.0 Salicylates	0.014	0.986	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.013	0.987	0.000
I78.8 Other diseases of capillaries	0.000	0.987	0.013
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.012	0.988	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.012	0.988	0.000
B34 Viral infection of unspecified site	0.000	0.989	0.011
T50.9 Other and unspecified drugs, medicaments and biological substances	0.011	0.989	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.989	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.010	0.990	0.000
T39.4 Antirheumatics, not elsewhere classified	0.010	0.990	0.000
T39.2 Pyrazolone derivatives	0.010	0.990	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.010	0.990	0.000
E10 Insulin-dependent diabetes mellitus	0.010	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
B34.4 Papovirus infection, unspecified	0.000	0.990	0.010
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.010	0.990	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.010	0.990	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.010	0.990	0.000
T44.0 Anticholinesterase agents	0.010	0.990	0.000
B34.8 Other viral infections of unspecified site	0.000	0.990	0.010
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.010	0.990	0.000
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.990	0.010
T37.8 Other specified systemic anti-infectives and antiparasitics	0.010	0.990	0.000
E10.4 With neurological complications	0.009	0.991	0.000
T50.8 Diagnostic agents	0.009	0.991	0.000
E10.5 With peripheral circulatory complications	0.009	0.991	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.009	0.991	0.000
T50.4 Drugs affecting uric acid metabolism	0.009	0.991	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.009	0.991	0.000
T50.1 Loop [high-ceiling] diuretics	0.009	0.991	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.009	0.991	0.000
T50.7 Analeptics and opioid receptor antagonists	0.009	0.991	0.000
T50.5 Appetite depressants	0.009	0.991	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.009	0.991	0.000
T50.0 Mineralocorticoids and their antagonists	0.009	0.991	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.009	0.991	0.000
K70-K77 Diseases of liver	0.000	0.991	0.009
U89.8 Agent resistant to other single specified antibiotic	0.000	0.991	0.009
B34.3 Parvovirus infection, unspecified	0.000	0.992	0.008
B34.2 Coronavirus infection, unspecified	0.000	0.992	0.008
B34.0 Adenovirus infection, unspecified	0.000	0.992	0.008
E10.2 With renal complications	0.008	0.992	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.008	0.992	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.992	0.008
T50.6 Antidotes and chelating agents, not elsewhere classified	0.008	0.992	0.000
B34.1 Enterovirus infection, unspecified	0.000	0.992	0.008
E10.6 With other specified complications	0.008	0.992	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.008	0.992	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.992	0.000
T37.5 Antiviral drugs	0.008	0.992	0.000
T37.4 Anthelminthics	0.008	0.992	0.000
T37.3 Other antiprotozoal drugs	0.008	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
T37.1 Antimycobacterial drugs	0.008	0.992	0.000
T37.0 Sulphonamides	0.008	0.992	0.000
E10.7 With multiple complications	0.008	0.992	0.000
I35.2 Aortic (valve) stenosis with insufficiency	0.000	0.992	0.008
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.007	0.992	0.000
E10.1 With ketoacidosis	0.008	0.992	0.000
E10.0 With coma	0.008	0.992	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.992	0.008
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.992	0.008
T47.6 Antidiarrhoeal drugs	0.007	0.993	0.000
E10.8 With unspecified complications	0.007	0.993	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.007	0.993	0.000
T36 Poisoning by systemic antibiotics	0.007	0.993	0.000
T47.2 Stimulant laxatives	0.007	0.993	0.000
T38.1 Thyroid hormones and substitutes	0.007	0.993	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.007	0.993	0.000
T38.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
T38.7 Androgens and anabolic congeners	0.007	0.993	0.000
T38.5 Other oestrogens and progestogens	0.007	0.993	0.000
T38.4 Oral contraceptives	0.007	0.993	0.000
T38.2 Antithyroid drugs	0.007	0.993	0.000
K71 Toxic liver disease	0.000	0.993	0.007
Z95.4 Presence of other heart-valve replacement	0.000	0.993	0.007
Q23.1 Congenital insufficiency of aortic valve	0.007	0.993	0.000
Q23 Congenital malformations of aortic and mitral valves	0.007	0.993	0.000
T38.0 Glucocorticoids and synthetic analogues	0.007	0.993	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.007	0.993	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.993	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
T47.7 Emetics	0.007	0.993	0.000
T47.5 Digestants	0.007	0.993	0.000
T47.3 Saline and osmotic laxatives	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.006	0.993	0.000
T49.9 Topical agent, unspecified	0.006	0.993	0.000
T49.8 Other topical agents	0.006	0.993	0.000
T49.7 Dental drugs, topically applied	0.006	0.993	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.006	0.993	0.000
T49.5 Ophthalmological drugs and preparations	0.006	0.993	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.006	0.993	0.000
T49.3 Emollients, demulcents and protectants	0.006	0.993	0.000
T49.2 Local astringents and local detergents	0.006	0.993	0.000
T49.1 Antipruritics	0.006	0.993	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.007	0.993	0.000
Z95.2 Presence of prosthetic heart valve	0.000	0.993	0.007
U89 Agent resistant to other and unspecified antibiotics	0.000	0.993	0.007
T41.5 Therapeutic gases	0.006	0.993	0.000
T41.4 Anaesthetic, unspecified	0.006	0.993	0.000
T41.3 Local anaesthetics	0.006	0.993	0.000
T41.2 Other and unspecified general anaesthetics	0.006	0.993	0.000
T41.1 Intravenous anaesthetics	0.006	0.993	0.000
T41.0 Inhaled anaesthetics	0.006	0.993	0.000
K77 Liver disorders in diseases classified elsewhere	0.000	0.994	0.006
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.006	0.994	0.000
T47.4 Other laxatives	0.006	0.994	0.000
T47.0 Histamine H(2)-receptor antagonists	0.006	0.994	0.000
T43.6 Psychostimulants with abuse potential	0.006	0.994	0.000
Q23.0 Congenital stenosis of aortic valve	0.006	0.994	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
Q23.3 Congenital mitral insufficiency	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.006	0.994	0.000
B27.9 Infectious mononucleosis, unspecified	0.000	0.994	0.006
Q27.8 Other specified congenital malformations of peripheral vascular system	0.006	0.994	0.000
Q27 Other congenital malformations of peripheral vascular system	0.006	0.994	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.994	0.006
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.006	0.994	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.006	0.994	0.000
T48.4 Expectorants	0.006	0.994	0.000
T48.3 Antitussives	0.006	0.994	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.006	0.994	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.006	0.994	0.000
T48.0 Oxytocic drugs	0.006	0.994	0.000
B27 Infectious mononucleosis	0.000	0.994	0.006
B25-B34 Other viral diseases	0.000	0.994	0.006
Q20-Q28 Congenital malformations of the circulatory system	0.006	0.994	0.000
T36.4 Tetracyclines	0.005	0.994	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.994	0.005
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.994	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.994	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.994	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.994	0.000
T45.4 Iron and its compounds	0.005	0.994	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.994	0.000
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.005	0.995	0.000
T36.8 Other systemic antibiotics	0.005	0.995	0.000
T36.7 Antifungal antibiotics, systemically used	0.005	0.995	0.000
T36.6 Rifamycins	0.005	0.995	0.000
T36.5 Aminoglycosides	0.005	0.995	0.000
T36.2 Chloramphenicol group	0.005	0.995	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.005	0.995	0.000
T48.5 Anti-common-cold drugs	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.005	0.995	0.000
N97.9 Female infertility, unspecified	0.000	0.995	0.005
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
U89.9 Agent resistant to unspecified antibiotic	0.000	0.995	0.005
K73 Chronic hepatitis, not elsewhere classified	0.000	0.995	0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
K71.8 Toxic liver disease with other disorders of liver	0.000	0.995	0.005
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.995	0.005
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.995	0.005
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.995	0.005
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.995	0.005
K71.2 Toxic liver disease with acute hepatitis	0.000	0.995	0.005
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.005	0.995	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.005	0.995	0.000
Q23.4 Hypoplastic left heart syndrome	0.005	0.995	0.000
Q23.2 Congenital mitral stenosis	0.005	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
K71.0 Toxic liver disease with cholestasis	0.000	0.995	0.005
Q28 Other congenital malformations of circulatory system	0.005	0.995	0.000
Q25 Congenital malformations of great arteries	0.005	0.995	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.995	0.005
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.995	0.005
T36.3 Macrolides	0.005	0.995	0.000
Z95.3 Presence of xenogenic heart valve	0.000	0.995	0.005
Q27.3 Peripheral arteriovenous malformation	0.005	0.995	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.005	0.995	0.000
T40.5 Cocaine	0.005	0.995	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.005	0.995	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.995	0.005
T43.4 Butyrophenone and thioxanthene neuroleptics	0.005	0.995	0.000
Q24 Other congenital malformations of heart	0.005	0.995	0.000
B27.0 Gammaherpesviral mononucleosis	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.995	0.000
K71.9 Toxic liver disease, unspecified	0.000	0.995	0.004
G80.9 Infantile cerebral palsy, unspecified	0.005	0.995	0.000
T40.3 Methadone	0.004	0.995	0.000
Q27.4 Congenital phlebectasia	0.004	0.995	0.000
Q27.2 Other congenital malformations of renal artery	0.004	0.995	0.000
Q27.1 Congenital renal artery stenosis	0.004	0.995	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.004	0.995	0.000
T36.0 Penicillins	0.004	0.995	0.000
Q24.0 Dextrocardia	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.004	0.996	0.000
T40.8 Lysergide [LSD]	0.004	0.996	0.000
T40.7 Cannabis (derivatives)	0.004	0.996	0.000
T40.1 Heroin	0.004	0.996	0.000
T40.0 Opium	0.004	0.996	0.000
B27.8 Other infectious mononucleosis	0.000	0.996	0.004
B27.1 Cytomegaloviral mononucleosis	0.000	0.996	0.004
Q25.0 Patent ductus arteriosus	0.004	0.996	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
B30 Viral conjunctivitis	0.000	0.996	0.004
B26 Mumps	0.000	0.996	0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
Q26 Congenital malformations of great veins	0.004	0.996	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.004	0.996	0.000
E28.2 Polycystic ovarian syndrome	0.000	0.996	0.004
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.996	0.004
Q28.0 Arteriovenous malformation of precerebral vessels	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
Q25.4 Other congenital malformations of aorta	0.004	0.996	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.996	0.004
Q24.6 Congenital heart block	0.004	0.996	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.996	0.004
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.996	0.004
Q25.3 Stenosis of aorta	0.004	0.996	0.000
K72 Hepatic failure, not elsewhere classified	0.000	0.996	0.004
Q25.6 Stenosis of pulmonary artery	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
Q24.4 Congenital subaortic stenosis	0.004	0.996	0.000
K81.9 Cholecystitis, unspecified	0.004	0.996	0.000
K75 Other inflammatory liver diseases	0.000	0.996	0.004
Q28.9 Congenital malformation of circulatory system, unspecified	0.004	0.996	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.004	0.996	0.000
Q28.1 Other malformations of precerebral vessels	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T40.6 Other and unspecified narcotics	0.004	0.996	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.996	0.004
Q25.9 Congenital malformation of great arteries, unspecified	0.004	0.996	0.000
Q25.8 Other congenital malformations of great arteries	0.004	0.996	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.004	0.996	0.000
Q25.5 Atresia of pulmonary artery	0.004	0.996	0.000
Q25.2 Atresia of aorta	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.004	0.996	0.000
U88 Agent resistant to multiple antibiotics	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
G80 Infantile cerebral palsy	0.004	0.996	0.000
K73.9 Chronic hepatitis, unspecified	0.000	0.996	0.004
B33 Other viral diseases, not elsewhere classified	0.000	0.996	0.004
K74.1 Hepatic sclerosis	0.000	0.996	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.996	0.004
U83 Resistance to other antibiotics	0.000	0.996	0.004
U82 Resistance to betalactam antibiotics	0.000	0.996	0.004
U85 Resistance to antineoplastic drugs	0.000	0.996	0.004
G80.0 Spastic cerebral palsy	0.004	0.996	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.996	0.004
Q24.3 Pulmonary infundibular stenosis	0.003	0.996	0.000
Q24.2 Cor triatriatum	0.003	0.996	0.000
Q24.1 Levocardia	0.003	0.996	0.000
T40.2 Other opioids	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.003	0.996	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.996	0.004
R82 Other abnormal findings in urine	0.000	0.996	0.004
Q28.3 Other malformations of cerebral vessels	0.003	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.996	0.000
I50.9 Heart failure, unspecified	0.000	0.997	0.003
S02.40 Fracture of malar and maxillary bones (closed)	0.003	0.997	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
T42.4 Benzodiazepines	0.003	0.997	0.000
B26.9 Mumps without complication	0.000	0.997	0.003
B26.8 Mumps with other complications	0.000	0.997	0.003
B26.3 Mumps pancreatitis	0.000	0.997	0.003
B26.2 Mumps encephalitis	0.000	0.997	0.003
B26.1 Mumps meningitis	0.000	0.997	0.003
B26.0 Mumps orchitis	0.000	0.997	0.003
B30.9 Viral conjunctivitis, unspecified	0.000	0.997	0.003
B30.8 Other viral conjunctivitis	0.000	0.997	0.003
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.000	0.997	0.003
B30.2 Viral pharyngoconjunctivitis	0.000	0.997	0.003
B30.1 Conjunctivitis due to adenovirus	0.000	0.997	0.003
B30.0 Keratoconjunctivitis due to adenovirus	0.000	0.997	0.003
W50.9 Unspecified place	0.003	0.997	0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.003	0.997	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.003	0.997	0.000
Q20.6 Isomerism of atrial appendages	0.003	0.997	0.000
Q20.5 Discordant atrioventricular connexion	0.003	0.997	0.000
Q20.4 Double inlet ventricle	0.003	0.997	0.000
Q20.3 Discordant ventriculoarterial connexion	0.003	0.997	0.000
Q20.2 Double outlet left ventricle	0.003	0.997	0.000
Q20.1 Double outlet right ventricle	0.003	0.997	0.000
Q20.0 Common arterial trunk	0.003	0.997	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.003	0.997	0.000
Q26.8 Other congenital malformations of great veins	0.003	0.997	0.000
Q26.6 Portal vein-hepatic artery fistula	0.003	0.997	0.000
Q26.5 Anomalous portal venous connexion	0.003	0.997	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.003	0.997	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.003	0.997	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.003	0.997	0.000
Q26.1 Persistent left superior vena cava	0.003	0.997	0.000
Q26.0 Congenital stenosis of vena cava	0.003	0.997	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.997	0.003
Q24.8 Other specified congenital malformations of heart	0.003	0.997	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.997	0.003
Q25.1 Coarctation of aorta	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
Chapter XXII Codes for special purposes	0.000	0.997	0.003
G80.2 Infantile hemiplegia	0.003	0.997	0.000
Q24.5 Malformation of coronary vessels	0.003	0.997	0.000
G80.8 Other infantile cerebral palsy	0.003	0.997	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.997	0.003
K75.2 Nonspecific reactive hepatitis	0.000	0.997	0.003
K75.1 Phlebitis of portal vein	0.000	0.997	0.003
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.997	0.003
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.997	0.003
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.997	0.003
Y91.9 Alcohol involvement, not otherwise specified	0.003	0.997	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.003	0.997	0.000
K83.8 Other specified diseases of biliary tract	0.003	0.997	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.003	0.997	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.003	0.997	0.000
Q22.6 Hypoplastic right heart syndrome	0.003	0.997	0.000
Q22.4 Congenital tricuspid stenosis	0.003	0.997	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.003	0.997	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.003	0.997	0.000
Q22.0 Pulmonary valve atresia	0.003	0.997	0.000
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.000	0.997	0.003
B33.3 Retrovirus infections, not elsewhere classified	0.000	0.997	0.003
B33.1 Ross River disease	0.000	0.997	0.003
B33.0 Epidemic myalgia	0.000	0.997	0.003
G80.4 Ataxic cerebral palsy	0.003	0.997	0.000
G80.3 Dyskinetic cerebral palsy	0.003	0.997	0.000
G80.1 Spastic diplegia	0.003	0.997	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.000	0.997	0.003
U81.0 Vancomycin resistant agent	0.000	0.997	0.003
B25 Cytomegaloviral disease	0.000	0.997	0.003
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.997	0.003
U82.8 Resistance to other betalactam antibiotics	0.000	0.997	0.003
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.997	0.003
U82.1 Resistance to methicillin	0.000	0.997	0.003
U82.0 Resistance to penicillin	0.000	0.997	0.003
U83.9 Resistance to unspecified antibiotic	0.000	0.997	0.003
U83.8 Resistance to other single specified antibiotic	0.000	0.997	0.003
U83.7 Resistance to multiple antibiotics	0.000	0.997	0.003
U83.2 Resistance to quinolones	0.000	0.997	0.003
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.997	0.003
U83.0 Resistance to vancomycin	0.000	0.997	0.003
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.997	0.003
U84.8 Resistance to other specified antimicrobial drug	0.000	0.997	0.003
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.997	0.003
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.997	0.003
U84.2 Resistance to antiviral drug(s)	0.000	0.997	0.003
U84.1 Resistance to antifungal drug(s)	0.000	0.997	0.003
U84.0 Resistance to antiparasitic drug(s)	0.000	0.997	0.003
C53.0 Endocervix	0.000	0.997	0.003
K70 Alcoholic liver disease	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
K72.1 Chronic hepatic failure	0.000	0.997	0.003
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.997	0.003
K72.0 Acute and subacute hepatic failure	0.000	0.997	0.003
Q22.1 Congenital pulmonary valve stenosis	0.003	0.997	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.000	0.997	0.003
R82.3 Haemoglobinuria	0.000	0.997	0.003
R82.2 Biliuria	0.000	0.997	0.003
R82.0 Chyluria	0.000	0.997	0.003
K74.0 Hepatic fibrosis	0.000	0.997	0.003
R82.1 Myoglobinuria	0.000	0.997	0.003
B33.8 Other specified viral diseases	0.000	0.997	0.002
B33.2 Viral carditis	0.000	0.997	0.002
W50.0 Home	0.003	0.997	0.000
Q22.5 Ebstein's anomaly	0.002	0.997	0.000
K75.0 Abscess of liver	0.000	0.997	0.003
L43.8 Other lichen planus	0.003	0.997	0.000
C18.1 Appendix	0.003	0.997	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.997	0.003
W50.8 Other specified place	0.003	0.997	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.002	0.997	0.000
U50 Level of care administered to neonates	0.000	0.997	0.003
U07 Emergency use of U07	0.000	0.997	0.003
U06 Emergency use of U06	0.000	0.997	0.003
U04 Severe acute respiratory syndrome [SARS]	0.000	0.997	0.003
U52 First in a series of a regular day/night admissions	0.000	0.997	0.003
K75.8 Other specified inflammatory liver diseases	0.000	0.997	0.003
R82.4 Acetonuria	0.000	0.997	0.002
T40.4 Other synthetic narcotics	0.002	0.997	0.000
K92.2 Gastro-intestinal haemorrhage, unspecified	0.003	0.997	0.000
U80.0 Penicillin resistant agent	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
L43 Lichen planus	0.003	0.997	0.000
C44.5 Skin of trunk	0.003	0.997	0.000
W50.4 Street and highway	0.002	0.998	0.000
Y65.8 Other specified misadventures during surgical and medical care	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.002
W50.3 Sports and athletics area	0.002	0.998	0.000
W50.7 Farm	0.002	0.998	0.000
W50.6 Industrial and construction area	0.002	0.998	0.000
W50.5 Trade and service area	0.002	0.998	0.000
W50.1 Residential institution	0.002	0.998	0.000
U51 Admission status on psychiatric patients	0.000	0.998	0.002
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.998	0.002
O72.0 Third-stage haemorrhage	0.000	0.998	0.002
H26.2 Complicated cataract	0.000	0.998	0.002
N97 Female infertility	0.000	0.998	0.002
B25.2 Cytomegaloviral pancreatitis	0.000	0.998	0.002
B25.1 Cytomegaloviral hepatitis	0.000	0.998	0.002
W51 Striking against or bumped into by another person	0.002	0.998	0.000
W50.2 School, other institution and public administrative area	0.002	0.998	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.998	0.002
W51.9 Unspecified place	0.002	0.998	0.000
E22.0 Acromegaly and pituitary gigantism	0.002	0.998	0.000
W51.5 Trade and service area	0.002	0.998	0.000
N30.8 Other cystitis	0.000	0.998	0.002
K70.3 Alcoholic cirrhosis of liver	0.000	0.998	0.002
R41.0 Disorientation, unspecified	0.000	0.998	0.002
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.998	0.002
W50-W64 Exposure to animate mechanical forces	0.002	0.998	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.998	0.002
U80.1 Methicillin resistant agent	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations